E-resources
Peer reviewed
Open access
-
Eser, Gökçe; Topaloğlu, Haluk
Genes, 07/2022, Volume: 13, Issue: 7Journal Article
Molecular treatments for Duchenne muscular dystrophy (DMD) are already in clinical practice. One particular means is exon skipping, an approach which has more than 15 years of background. There are several promising clinical trials based on earlier works. The aim is to be able to initiate the production of enough dystrophin to change the rate of progression and create a clinical shift towards the better. Some of these molecules already have received at least conditional approval by health authorities; however, we still need new accumulating data.
